Justification of the choice of minimally invasive technologies in the treatment of submucosal tumors of the stomach
https://doi.org/10.24884/1607-4181-2025-32-3-68-77
Abstract
The objective was to improve the treatment results in patients with submucosal tumors of the stomach.
Methods and materials. 70 cases of treatment of patients with submucosal tumors of the stomach who underwent endoscopic and combined interventions were analyzed.
Results. In all the presented cases, the ST was removed, and the intraoperative and early postoperative complications that occurred were eliminated using endoscopic techniques and laparoscopic intervention. Based on the experience gained, criteria for the selection of removal techniques (endoscopic and in combination with surgery) were determined based on the size of the ST, its location in the stomach, as well as the presence of compromised mucosa above the ST. No relapses were noted during follow-up.
About the Authors
M. M. SaadulaevaRussian Federation
Saadulaeva Marina M., Senior Laboratory Assistant of the Department of Hospital Surgery № 2, Endoscopist of the Endoscopy Department № 1 of the Research Institute of Surgery and Emergency Medicine
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
Authors declare no conflict of interest.
Ya. V. Ruchkina
Russian Federation
Ruchkina Yana V., Postgraduate Student of the Department of Hospital Surgery № 2, Endoscopist of the Endoscopy Department № 1 of the Research Institute of Surgery and Emergency Medicine
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
Authors declare no conflict of interest.
A. Yu. Korolkov
Russian Federation
Korolkov Andrey Yu., Dr. of Sci. (Med.), Professor, Head of the Department of Hospital Surgery № 2 with Clinic, Head of the Department of General and Emergency Surgery of the Research Institute of Surgery and Emergency Medicine
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
Authors declare no conflict of interest.
E. V. Blinov
Russian Federation
Blinov Egor V., Endoscopist of the Endoscopy Department № 1 of the Research Institute of Surgery and Emergency Medicine
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
Authors declare no conflict of interest.
A. A. Smirnov
Smirnov Alexander A., Dr. of Sci. (Med.), Associate Professor of the Department of Hospital Surgery № 2 with Clinic, Head of the Endoscopy Department of the Research Institute of Surgery and Emergency Medicine
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
Authors declare no conflict of interest.
References
1. Starkov Iu. G., Solodinina E. N., Novozhilova A. V. Submucosal neoplasms of gastrointestinal tract in endoscopic practice // Pirogov Russian Journal of Surgery. 2010;(2):51–59. (In Russ.).
2. Vashakmadze L. A., Kolobaev I. V., Bespalov P. D. et al. Gastrointestinal stromal tumors: classification, diagnosis, and treatment // P. A. Herzen Journal of Oncology. 2013;2(2):66–70. (In Russ.). https://doi.org/10.17116/endoskop20212704147.
3. Dzhantukhanova S. V., Starkov Yu. G., Zamolodchikov R. D. et al. The techniques of hybrid laparo-endoscopic resections for non-epithelial gastric tumors // Endoscopic Surgery. 2021;27(4):47–60. (In Russ.). https://doi.org/10.17116/endoskop20212704147.
4. Fletcher C. D., Berman J. J., Colress C. et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach // Hum Patol. 2002;33:459–465.
5. Dalal I., Andalib I. Advances in endoscopic resection: a review of endoscopic submucosal dissection (ESD), endoscopic full thickness resection (EFTR) and submucosal tunneling endoscopic resection (STER) // Transl Gastroenterol Hepatol. 2022;7:19. https://doi.org/10.21037/tgh-2020-10.
6. Akahoshi K., Oya M., Koga T., Shiratsuchi Y. Current clinical management of gastrointestinal stromal tumor // World J Gastroenterol. 2018;24(26):2806–2817. https://doi.org/10.3748/wjg.v24.i26.2806.
7. Modlin I. M., Lye K. D., Kidd M. Carcinoid tumors of the stomach // Surg Oncol. 2003;12:153–172. https://doi.org/10.1016/S0960-7404(03)00034-3.
8. Cherübl H., Cadiot G., Jensen R. T. et al. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? // Endoscopy. 2010;42:664–671. PMID: 20669078. https://doi.org/10.1055/s-0030-1255564.
9. Kidd M., Modlin I. M., Mane S. M. et al. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease // Ann Surg. 2006;243:273–280.
10. Crosby D. A., Donohoe C. L., Fitzgerald L. et al. Gastric neuroendocrine tumours // Dig Surg. 2012;29:331–348. PMID: 23075625. https://doi.org/10.1159/000342988.
11. Jacobson B. C., Bhatt A., Greer K. B. et al. ACG Clinical Guideline: Diagnosis and Management of Gastrointestinal Subepithelial Lesions // Am J Gastroenterol. 2023;118(1):46– 58. https://doi.org/10.14309/ajg.0000000000002100.
12. Hirota S., Tateishi U., Nakamoto Y. et al. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology // Int J Clin Oncol. 2024;29(6):647–680. https://doi.org/10.1007/s10147-024-02488-1.
13. Aslanian H. R., Sethi A., Bhutani M. S. et al. ASGE guideline for endoscopic full thickness resection and submuco-sal tunnel endoscopiс resection // VideoGIE. 2019;4(8): 343–350.
14. Deprez P. H., Moons L. M. G., OʼToole D. et al. Endoscopic management of subepithelial lesions includ ing neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline // Endoscopy. 2022; 54(4):412–429. https://doi.org/10.1055/a-1751-5742.
15. Seo H. Surgical approaches for subepithelial tumors in difficult locations of the gastrointestinal tract // Foregut Surg. 2024;4(2):51–56. https://doi.org/10.51666/fs.2024.4.e8.
16. Jacobson B. C., Bhatt A., Greer K. B. et al. ACG Clinical Guideline: Diagnosis and Management of Gastrointestinal Subepithelial Lesions // Am J Gastroenterol. 2023;118(1):46–58. https://doi.org/10.14309/ajg.0000000000002100. PMID: 36602835.
17. Judson I., Jones R. L., Wong N. A. C. S. et al. Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines // Br J Cancer. 2025;132(1):1– 10. https://doi.org/10.1038/s41416-024-02672-0. PMID: 38840030; PMCID: PMC11723931.
18. Khvorova I. I. Endoscopic treatment of patients with subepithelial neoplasms of the stomach. Diss. ... Cand. of Sci. (Med.): 3.1.9. M., 2023. 200 p. (In Russ.).
19. Nikulin M. P., Arkhiri P. P., Nosov D. A. et al. Gastrointestinal stromal tumors. RUSSCO practical recommendations, part 1.1 // Malignant tumors. 2024;14(3s2):416–426. (In Russ.). https://doi.org/10.18027/2224-5057-2024-14-3s2-1.1-19.
20. He C. H., Lin S. H., Chen Z. et al. Laparoscopic-assisted endoscopic full-thickness resection of a large gastric schwannoma: A case report // World J Gastrointest. Surg. 2022; 14(4):362–369. https://doi.org/10.4240/wjgs.v14.i4.362.
21. Buldanlı M. Z., Yener O. Endoscopic Resection of Upper Gastrointestinal Subepithelial Tumours: Our Clinical Experience and Results // Prague Med Rep. 2022;123(1):20– 26. https://doi.org/10.14712/23362936.2022.2.
22. Santos-Antunes J., Marques M., Morais R. Retrospective analysis of the outcomes of endoscopic submucosal dissection for the diagnosis and treatment of subepithelial lesions in a center with high expertise // Ann Gastroenterol. 2022;35(1):68–73. https://doi.org/10.20524/aog.2021.0675.
23. Matsui H., Tamai N., Futakuchi T. et al. Multi-loop traction device facilitates gastric endoscopic submucosal dissection: ex vivo pilot study and an inaugural clinical experience // BMC Gastroenterol. 2022;22(1):10. https://doi.org/10.1186/s12876-021-02085-w.
Supplementary files
Review
For citations:
Saadulaeva M.M., Ruchkina Ya.V., Korolkov A.Yu., Blinov E.V., Smirnov A.A. Justification of the choice of minimally invasive technologies in the treatment of submucosal tumors of the stomach. The Scientific Notes of the Pavlov University. 2025;32(3):68-77. (In Russ.) https://doi.org/10.24884/1607-4181-2025-32-3-68-77


































